Abstract
Aim/Objectives
This prospective study aims to assess the efficacy of hyperbaric oxygen therapy in diabetic foot ulcers in relation to standard wound care.
Methods
This was a single centre prospective study conducted from January 2007 to March 2015 by the department of surgery. In total, 240 consenting patients with foot ulcers of at least two weeks duration were randomized with the help of a random number generator into two groups each comprising 120 patients: the HBOT group (to receive hyperbaric oxygen therapy along with standard wound care) and the ASD group (to receive standard wound care only). The six-week treatment phase was followed by a six-week follow-up phase. Wounds were monitored using the Bates-Jensen Wound assessment scale. For all statistical analysis, a p-value of less than 0.05 was taken to indicate a significant difference.
Results
Of the 240 patients, 164 were male and 36 female. The duration of diabetes was not statistically significant (p-value 0.707). In the study group, the wounds of 22 (88) (73.3%) patients healed in less than eight weeks (i.e. 56 days), vs. only 4(16) (13.3%) patients in the control group, which was statistically significant (p value <0.001)
Conclusion
This study further supports and recommends HBOT for the management of diabetic foot ulcers as there is marked increase in the rate of wound healing as compared to standard wound care and dressings alone.
Article PDF
Similar content being viewed by others
References
Powers AC. Diabetes Mellitus. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Loscalzo J (eds). Harrison’s Principles of Internal Medicine, 18th ed. United States of America: The McGraw Hill companies, Inc; 2012; 2968–70
Shankhdhar KLK, Shankhdhar U, Shankhdhar S. Diabetic foot problems in India: An overview and potential simple approaches in a developing country. Current Diabetes Reports 2008; 8: 452–7
Viswanathan V, Shobhana R, Snehalatha C, et al. Need for education on foot care in diabetic patients in India. J Assoc Physicians India 2009; 47: 1083–5
Shobhana R, Rao PR, Lavanya A, et al. Cost burden to diabetic patients with foot complications: a study from Southern India. J Assoc Physicians India 2000; 48: 1147–50
Bates-Jensen BM, McNees P. Toward an intelligent wound assessment system. Ostomy/Wound management 1995; 41: 805–65
Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27: 1047–53
Reiber GE. The epidemiology of diabetic foot problems. Diabet Med 1996; 13(suppl 1):S6–S11
Reiber GE. Epidemiology of foot ulcers and amputations in the diabetic foot. Bowker JH, Pfeifer MA (eds). The Diabetic Foot. St Louis, Mo: Mosby; 2001; pp. 13–32
International Working Group on the Diabetic Foot. Epidemiology of diabetic foot infections in a populationbased cohort. Paper presented at: International Consensus on the Diabetic Foot; May 22-24, 2003; Noordwijkerhout, the Netherlands
Lavery LA, Armstrong DG, Wunderlich RP, et al. Diabetic foot syndrome: evaluating the prevalence and incidence of foot pathology in Mexican Americans and non-Hispanic whites from a diabetes disease management cohort. Diabetes Care 2003; 26: 1435–8
Gregg EW, Sorlie P, Paulose-Ram R, et al. Prevalence of lowerextremity disease in the US adult population 40 years of age with and without diabetes: 1999-2000 National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 1591–7
Harrington C, Zagari MJ, Corea J, et al. A cost analysis of diabetic lower extremity ulcers. Diabetes Care 2000; 23: 1333–8
Kaur S, Pawar M, Banerjee N, et al. Evaluation of the efficacy of hyperbaric oxygen therapy in the management of chronic non healing ulcer and role of periwound transcutaneous oximetry as a predictor of wound healing response: A randomized prospective controlled trial. J Anaesthesiol Clin Pharmacol 2012; 28: 70–5
Chaudhary P, Khandelwal S, Poddar D, et al. Comparative study of different treatment options of grade III and IV diabetic foot ulcers to reduce the incidence of amputations. Clinics and Practice 2013; 3: 20–4
Abidia A, Laden G, Kuhan G, et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur J VascEndovasc Surg 2003; 25: 513–8; doi: 10.1053/ejvs.2002.1911
Londhal M, Katzman P, Nilsson A, et al. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care 2010; 33: 5:998-1003
Kessler L, Bilbault P, Ortega F, et al. Hyperbaric oxygenation accelerates the healing rate of nonischemicchronic diabetic foot ulcers: a prospective randomized study. Diabetes Care 2003; 26: 2378–82; doi: 10.2337/diacare.26.8.2378
Kalani M, Jorneskog G, Naderi N, et al. Hyperbaric oxygen therapy for wound healing and limb salvage in diabetic foot lesions: three year follow-up. Undersea Hyperb Med 2000; 27(Suppl):44–5
Baroni G, Porro T, Figlia E, et al. Hyperbaric oxygen in diabetic gangrene treatment. Diabetes Care 1987; 10: 81–6
Oriani G, Meazza D, Favales F, Pizzi GL, Aldeghi A, Faglia E. Hyperbaric oxygen in diabetic gangrene. Journal of Hyperbaric Medicine 1990; 5: 171–5
Faglia E, Favales F, Aldeghi A, et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care 1996; 19: 1338–43. doi: 10.2337/diacare.19.12.1338
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Munjewar, C., Nabi, I., Gautam, S. et al. Evaluation of the role of hyperbaric oxygen therapy in the treatment of diabetic foot ulcers: a prospective comparative study. Hellenic J Surg 88, 219–224 (2016). https://doi.org/10.1007/s13126-016-0321-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13126-016-0321-y